HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

J. Biol. Chem., Vol. 276, Issue 11, 8254-8260, March 16, 2001

This Article Full Text Full Text (PDF) All Versions of this Article: 276/11/8254    most recent M009798200v1 Submit a Letter to Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Roubert, C. Articles by Giros, B. Search for Related Content PubMed PubMed Citation Articles by Roubert, C. Articles by Giros, B. Social Bookmarking                      What's this?

Determination of Residues in the Norepinephrine Transporter That Are Critical for Tricyclic Antidepressant Affinity^*

Christine Roubert^§¶, Peter J. Cox^§, Michael Brüss^**, Michel Hamon^§, Heinz Bönisch^**, and Bruno Giros^§

From  INSERM U-513, Neurobiologie et Psychiatrie, Faculté de Médecine de Créteil, 8, rue du Général Sarrail, F-94000 Créteil, France, ^§ INSERM U-288, Neuropsychopharmacologie Moléculaire, Cellulaire et Fonctionnelle, Faculté de Médecine Pitié-Salpêtrière, 91, Boulevard de l'Hôpital, F-75013 Paris, France, and the ^** Institute of Pharmacology and Toxicology, University of Bonn, Reuterstraße 2 b, D-53113 Bonn, Germany

The norepinephrine (NET) and dopamine (DAT) transporters are highly homologous proteins, displaying many pharmacological similarities. Both transport dopamine with higher affinity than norepinephrine and are targets for the psychostimulants cocaine and amphetamine. However, they strikingly contrast in their affinities for tricyclic antidepressants (TCA). Previous studies, based on chimeric proteins between DAT and NET suggest that domains ranging from putative transmembrane domain (TMD) 5 to 8 are involved in the high affinity binding of TCA to NET. We substituted 24 amino acids within this region in the human NET with their counterparts in the human DAT, resulting in 22 different mutants. Mutations of residues located in extra- or intracytoplasmic loops have no effect on binding affinity of neither TCA nor cocaine. Three point mutations in TMD6 (F316C), -7 (V356S), and -8 (G400L) induced a loss of TCA binding affinity of 8-, 5-, and 4-fold, respectively, without affecting the affinity of cocaine. The triple mutation F316C/V356S/G400L produced a 40-fold shift in desipramine affinity. These three residues are strongly conserved in all TCA-sensitive transporters cloned in mammalian and nonmammalian species. A strong shift in TCA affinity (IC₅₀) was also observed for double mutants F316C/D336T (35-fold) and S399P/G400L (80-fold for nortriptyline and 1000-fold for desipramine). Reverse mutations P401S/L402G in hDAT did not elicit any gain in TCA affinities, whereas C318F and S358V resulted in a 3- and 10-fold increase in affinity, respectively. Our results clearly indicate that two residues located in TMD6 and -7 of hNET may play an important role in TCA interaction and that a critical region in TMD8 is likely to be involved in the tertiary structure allowing the high affinity binding of TCA.

CiteULike

Complore

Connotea

Del.icio.us

Digg

Reddit

Technorati

This article has been cited by other articles:

				J. Zhu, S. Apparsundaram, and L. P. Dwoskin Nicotinic Receptor Activation Increases [3H]Dopamine Uptake and Cell Surface Expression of Dopamine Transporters in Rat Prefrontal Cortex J. Pharmacol. Exp. Ther., March 1, 2009; 328(3): 931 - 939. [Abstract] [Full Text] [PDF]

				Z. Zhou, J. Zhen, N. K. Karpowich, R. M. Goetz, C. J. Law, M. E. A. Reith, and D.-N. Wang LeuT-Desipramine Structure Reveals How Antidepressants Block Neurotransmitter Reuptake Science, September 7, 2007; 317(5843): 1390 - 1393. [Abstract] [Full Text] [PDF]

				F. A. Paczkowski, I. A. Sharpe, S. Dutertre, and R. J. Lewis {chi}-Conotoxin and Tricyclic Antidepressant Interactions at the Norepinephrine Transporter Define a New Transporter Model J. Biol. Chem., June 15, 2007; 282(24): 17837 - 17844. [Abstract] [Full Text] [PDF]

				M. K. Hahn, M. S. Mazei-Robison, and R. D. Blakely Single Nucleotide Polymorphisms in the Human Norepinephrine Transporter Gene Affect Expression, Trafficking, Antidepressant Interaction, and Protein Kinase C Regulation Mol. Pharmacol., August 1, 2005; 68(2): 457 - 466. [Abstract] [Full Text] [PDF]

				I. A. Sharpe, E. Palant, C. I. Schroeder, D. M. Kaye, D. J. Adams, P. F. Alewood, and R. J. Lewis Inhibition of the Norepinephrine Transporter by the Venom Peptide {chi}-MrIA: SITE OF ACTION, Na+ DEPENDENCE, AND STRUCTURE-ACTIVITY RELATIONSHIP J. Biol. Chem., October 10, 2003; 278(41): 40317 - 40323. [Abstract] [Full Text] [PDF]

				L. J. Bryan-Lluka, H. Bonisch, and R. J. Lewis {chi}-Conopeptide MrIA Partially Overlaps Desipramine and Cocaine Binding Sites on the Human Norepinephrine Transporter J. Biol. Chem., October 10, 2003; 278(41): 40324 - 40329. [Abstract] [Full Text] [PDF]

				T. Horishita, K. Minami, N. Yanagihara, M. Shiraishi, T. Okamoto, Y. Shiga, S. Ueno, and A. Shigematsu Alphaxalone, a Neurosteroid Anesthetic, Inhibits Norepinephrine Transporter Function in Cultured Bovine Adrenal Medullary Cells Anesth. Analg., December 1, 2002; 95(6): 1661 - 1666. [Abstract] [Full Text] [PDF]

				K. Sagata, K. Minami, N. Yanagihara, M. Shiraishi, Y. Toyohira, S. Ueno, and A. Shigematsu Tramadol Inhibits Norepinephrine Transporter Function at Desipramine-Binding Sites in Cultured Bovine Adrenal Medullary Cells Anesth. Analg., April 1, 2002; 94(4): 901 - 906. [Abstract] [Full Text] [PDF]

				C. Roubert, C. Sagne, M. Kapsimali, P. Vernier, F. Bourrat, and B. Giros A Na+/Cl--Dependent Transporter for Catecholamines, Identified as a Norepinephrine Transporter, Is Expressed in the Brain of the Teleost Fish Medaka (Oryzias latipes) Mol. Pharmacol., September 1, 2001; 60(3): 462 - 473. [Abstract] [Full Text] [PDF]